Early life nutrition can inevitably affect a child’s growth and development and the gut microbiome plays a vital part in it. Current research still focuses on bringing infant formula closer to human milk, with some comprising probiotics. China is a major contributor to the global infant formula market. However, the once-booming market has seen growth slow due to decreasing birth rate, meaning infant formula companies are engaged in a heated race to find new growth drivers. Can bifidobacteria supplementation in infant formula help grow market success? Join our expert speakers as they discuss the market insights, regulatory framework, and scientific basis of bifidobacteria probiotics in infant nutrition.
